The Society of Gynecologic Oncology (SGO) will recognize Henry T. Lynch, M.D., for his lifetime dedication to understanding the role of genetics in cancer when they award him the Foundation of Gynecologic Oncology's 2014 Innovation Award this spring.
Lynch, the chairman of preventive medicine and public health, professor of medicine and director of the Hereditary Cancer Center at Creighton University, is often credited as the father hereditary cancer for his work in developing the cardinal principles of cancer genetics and in helping identify multiple genetic cancer syndromes. The Foundation's Innovation Award particularly recognizes his impact in the understanding of and approaches to the prevention, diagnosis and treatment of gynecologic cancer, such as hereditary breast-ovarian cancer syndrome.
"His accomplishments have saved the lives of untold numbers of people, set the course for a broad swath of cancer research for years to come and impacted career paths for generations of researchers and health practitioners," writes SGO President Barbara A. Goff, M.D.
"The bulk of this work is mostly attributable to the many colleagues at Creighton University who have not only worked with me, but believed in my work and had faith in its ultimate potential for saving lives," says Lynch.
The Foundation's Innovation Award was established in 2011 to honor those who have been exceptionally creative thinkers in the field of gynecologic cancers. Previous winners include Nobel Laureate Harald zur Hausen, DSc, M.D., for his discovery of the role of the human papillomavirus in cervical cancer, and the late C. Thomas Griffiths, M.D., for his work in cytoreductive surgery in ovarian cancer.
Lynch will accept the award on March 22 at the Society's 45th Annual Meeting on Women's Cancer in Tampa, Fla.